Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

randed Pharmaceuticals$398,267

$  368,840

8%$  773,781

$707,376

9%Total Generics$133,047

$  27,684

381%$267,456

$  53,560

399%Device and ServicesHealthTronics$
49,485

NM$
99,588

NMAMSMen's Health$   9,768

$  —

NM$
9,768

$  —

NMWomen's Health7,787

NM7,787

NMBPH Therapy9,257

NM9,257

NMUterine Health(2)—

NM—

NMSub-total$
26,812

$  —

NM$  26,812

$  —

NMTotal Device and Services$
76,297

$  —

NM$126,400

$  —

NMTotal Revenue$
7,611

$396,524

53%$1,167,637

$760,936

53%(1) To conform to current year presentation, net sales from our non-time released formulation of Opana® have been reclassified and are now included within other branded product results.(2)The uterine health product line, Her Option® was sold in February 2010.  Revenues for 2010 consist of end-customer revenue earned prior to the date of sale, in addition to revenue earned as part of the product supply agreement with CooperSurgical, Inc., which continued through the fourth quarter of 2010.The following table presents Endo's unaudited Net Pro forma Revenues for the six quarters ended June 30, 2011 giving effect to the  AMS acquisition, the Qualitest acquisition, the Penwest acquisition and the HealthTronics, Inc. acquisition as if they had occurred on January 1, 2010 :

Endo Pharmaceuticals Holdings Inc.
Net Pro Forma Revenues (unaudited)
(in thousands)2010

2011Q1

Q2

Q3

Q4

Q1

Q2Branded PharmaceuticalsLIDODERM®

$182,607

$196,090

$196,
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Hologic, Inc. (NASDAQ: HOLX ... President and Chief Executive Officer, will preside over the ... the first day of Breast Cancer Awareness Month. In ... focused on the important benefits of Hologic,s 3D Mammography ... as clinically superior to traditional mammography. ...
(Date:9/30/2014)... 30, 2014 This study provides an ... informatics solutions including nuclear imaging informatics, PET imaging ... study assesses the size of the market based ... and projects future growth based on the current ... taking place in the broader markets for imaging ...
(Date:9/30/2014)... , Sept. 30, 2014 Aileron ... Summary Global Markets Direct,s, ,Aileron Therapeutics, ... an overview of the Aileron Therapeutics, Inc.,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... at various stages, therapeutics assessment by drug target, ...
Breaking Medicine Technology:Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3
... OrthoWorx, the newly formed industry, community and education initiative to ... is working to connect the orthopedics capital of the world ... , In a September report, Warsaw, ... overview, analysis and blueprint for future industry and community growth, ...
... , , KNOXVILLE, Tenn., Dec. 15 Medical researchers ... their revolutionary new technology for a simple blood test to ... of its pre-clinical trials for the ColoMarker(TM) assay, EDP has ... of its use. Via an inexpensive blood test, ColoMarker(TM) ...
Cached Medicine Technology:OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
(Date:10/1/2014)... October 01, 2014 Join the more than ... Disorder Treatment Center’s first ever charity golf tournament to benefit ... with eating disorders who cannot afford treatment. The tournament will ... in Eureka, Mo. , The day-long event starts with ... reception and award dinner will begin at 5 p.m. and ...
(Date:10/1/2014)... Jupiter, FL (PRWEB) October 01, 2014 ... Begley, Jr., scheduled to broadcast on Monday, October 20, ... In this episode, Innovations will go behind the scenes ... prevention programs. This segment will explore the practical help ... young adults, which teaches the warning signs of abuse, ...
(Date:10/1/2014)... 01, 2014 Scientists at the University ... that target immune system proteins has the power to ... posted details of the new study on their website. ... , Researchers in the UWA School of Pathology and ... to mice with mesothelioma with promising results. , ...
(Date:10/1/2014)... October 01, 2014 October is national ... and early detection plans while raising money for breast ... Breast Cancer Awareness Month in the effort to ... to promote the importance of having access to clean, ... may be linked to certain forms of cancer. ...
(Date:10/1/2014)... WA (PRWEB) October 01, 2014 Two ... will take them across the country in an effort ... today’s military families. The cyclists, a father-daughter team, ... states, beginning in Blaine, Washington and finishing in Key ... benefit Hope For The Warriors®, a national nonprofit organization ...
Breaking Medicine News(10 mins):Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2
... may indicate more severe depression, rather than direct cause-and-effect, ... Women who use antidepressants appear to be at heightened ... of the link remains unclear, researchers say. , The ... the researchers said. , "We suspect that their ...
... of the U.S. Conference of Catholic Bishops, Committee on ... embryonic stem cell research "a sad victory of politics ... first time in U.S. history, federal tax dollars will ... embryos for stem cell research. Cardinal Rigali also cited ...
... MARCOS, Calif., March 9 Natural Alternatives International, Inc. ... formulator and manufacturer of customized nutritional supplements, and ... based distributor of raw materials to the sports ... industries, today jointly announced their licensing agreement of ...
... condensed format at 15 locations statewide and online to ... PARK, Pa., March 9 School nurses in Pennsylvania ... with Penn State,s Professional Development Program for ... new courses for the program, to include timely, relevant ...
... (Nasdaq: MDVN ) today announced that ... discuss fourth quarter and year-end 2008 financial results and provide ... 4:30 p.m. Eastern Time. A press release for the fourth ... after markets close on March 16, 2009. Interested parties may ...
... In Kentucky, nearly one out of every two of ... a quarter of the dentists accept the insurance; therefore ... it comes to seeing a dentist or receiving dental ... Healthcare, manufacturer of Aquafresh(R) and Sensodyne(R), has donated 10,000 ...
Cached Medicine News:Health News:Antidepressant Use Tied to Cardiac Death in Women 2Health News:Antidepressant Use Tied to Cardiac Death in Women 3Health News:Executive Order on Embryonic Stem Cells 'A Sad Victory of Politics Over Science and Ethics,' Says Cardinal Rigali 2Health News:Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement 2Health News:Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement 3Health News:Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement 4Health News:Penn State Expands Professional Development Program for School Nurses, Now in its Seventh Year 2Health News:Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009 2Health News:GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia 2
Anatomically designed 3 cervical foam collar...
One-piece rigid cervical collar is designed to fit securely around the neck and mandible to provide immobilization and support of the cervical region...
This model utilizes the Malibu Soft Cervical Collar with a Thoracic Extension....
Model C-10 is a four post cervical orthosis which controls flexion, extension, lateral flexion, rotation, and axial motion. Each post may be individually adjusted in height....
Medicine Products: